search icon
      blog search icon

      Aytu BioPharma, Inc. (AYTU) Stock Surges Following Developments Stemming from Merger with Neos - Stocks Telegraph

      By ST Staff

      Published on

      June 21, 2021

      4:58 PM UTC

      Aytu BioPharma, Inc. (AYTU) Stock Surges Following Developments Stemming from Merger with Neos - Stocks Telegraph

      Aytu BioPharma, Inc. (AYTU) stock prices were up a significant 13.85% shortly after market trading commenced on June 21st, 2021, bringing the price up to USD$5.39 early on in the trading day.

      Net Revenue Reports

      Net revenue for the third quarter of the fiscal year 2021 was reported at USD$13.5 million, up from the USD$8.2 million reported for the same quarter of the prior fiscal year. This increase is largely attributable to the continued increase in sales through organic product growth, as well as through the realization of the recently completed Neos transaction.

      Net Revenue Breakdown

      Net revenue generated from the consumer health division was reported at USD$8.4 million, a significant increase over the USD$3.5 million reported for the same quarter of the prior fiscal year. This increase was largely attributable to the multiple product launches over the 2021 quarter. Further compounding the year-over-year increases, the growth of the company’s e-commerce channel has greatly increased its scope. The Rx division reported generating net revenue in the amount of USD$5.1 million, up from the USD$4.7 million reported in the year-ago quarter.  The increase was largely driven by product revenue arising from the transaction with Neo, which closed on March 19th, 2021.

      Net Loss Reports

      Net loss for the first quarter of fiscal 2021 came in at USD$25.5 million, representing a net loss of USD$1.41 per share of common stock The year-over-year increase primarily resulted from expenses related to the Neos merger, amounting to a total of USD$10.6 million. A USD$7.1 million write-offs in slow-moving inventory for the quarter also contributed to the yearly difference.

      Solid Liquidity Position

      The company reported a solid liquidity position, with cash, cash equivalents, and restricted cash amounting to USD$46.8 million as of March 31st, 2021. This report comes after the company made a principal payment of USD$15 million toward the Deerfield Note held by Neos.

      Future Outlook for AYTU

      Armed with a solid liquidity position, AYTU is poised to continue its trajectory of success in light of the opportunities afforded to it by its merger with Neos. Current and potential investors are hopeful that management will continue to leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

      More From Stocks telegraph